2-Amino-6-chloro-N-((1-(4-(methylsulfonyl)piperazin-1-yl)-cyclohexyl)methyl)benzamide Hydrochloride

ID: ALA4581616

Chembl Id: CHEMBL4581616

PubChem CID: 117897992

Max Phase: Preclinical

Molecular Formula: C19H30Cl2N4O3S

Molecular Weight: 428.99

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  CS(=O)(=O)N1CCN(C2(CNC(=O)c3c(N)cccc3Cl)CCCCC2)CC1.Cl

Standard InChI:  InChI=1S/C19H29ClN4O3S.ClH/c1-28(26,27)24-12-10-23(11-13-24)19(8-3-2-4-9-19)14-22-18(25)17-15(20)6-5-7-16(17)21;/h5-7H,2-4,8-14,21H2,1H3,(H,22,25);1H

Standard InChI Key:  XMTKEGDGQPITTE-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 428.99

Molecular Weight (Monoisotopic): 428.1649

AlogP: 1.93

#Rotatable Bonds: 5

Polar Surface Area: 95.74

Molecular Species: NEUTRAL

HBA: 5

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 7

HBD (Lipinski): 3

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 6.64

CX LogP: 1.78

CX LogD: 1.71

Aromatic Rings: 1

Heavy Atoms: 28

QED Weighted: 0.70

Np Likeness Score: -1.48

References

1. Cioffi CL, Liu S, Wolf MA, Guzzo PR, Sadalapure K, Parthasarathy V, Loong DT, Maeng JH, Carulli E, Fang X, Karunakaran K, Matta L, Choo SH, Panduga S, Buckle RN, Davis RN, Sakwa SA, Gupta P, Sargent BJ, Moore NA, Luche MM, Carr GJ, Khmelnitsky YL, Ismail J, Chung M, Bai M, Leong WY, Sachdev N, Swaminathan S, Mhyre AJ..  (2016)  Synthesis and Biological Evaluation of N-((1-(4-(Sulfonyl)piperazin-1-yl)cycloalkyl)methyl)benzamide Inhibitors of Glycine Transporter-1.,  59  (18): [PMID:27559615] [10.1021/acs.jmedchem.6b00914]

Source

Source(1):

• Scientific Literature